The global automated cell counters market is poised to grow owing to increasing incidence of chronic and infectious diseases. Automated cell counters help in disease diagnosis by providing accurate and rapid cell counts. These devices facilitate automated detection and enumeration of various blood cells like red blood cells, white blood cells and platelets. They assist in clinical diagnosis ofconditions like anemia, leukemia and infections by identifying abnormalities in cell counts.

Automated cell counters offer various advantages over manual cell counting methods. They provide reproducible, accurate and precise cell counts within a short timeframe. This helps clinicians in early disease diagnosis and timely treatment initiation. Automated cell counters employ advanced optics, fluidics and image analysis technologies to automatically load the sample, capture high-resolution images of cells and count them based on pre-defined parameters. The automated workflow eliminates human errors and reduces lab workload associated with manual methods.

The global automated cell counters market is estimated to be valued at US$ 3.75 Bn in 2024 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030.

Key Takeaways

Key players operating in the automated cell counters are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, and Tecan. Thermo Fisher Scientific and Danaher Corporation collectively hold over 50% of the market share.

The rising geriatric population and increasing incidence of chronic and infectious diseases are major demand drivers for automated cell counters. According to the World Health Organization, chronic diseases accounted for 71% of global deaths in 2019. This has boosted diagnostic testing volumes globally.

Technological advancements are expanding the scope of automated cell counters. Newer models offer advanced features like immunity cell profiling, biomarker detection, and integration with laboratory information systems. This widens their applications from basic cell counting to specialized diagnostic testing.

Market Trends

Artificial intelligence and machine learning: Major players are integrating AI and ML algorithms into cell counters. This enhances image analysis capabilities, automates diagnostic interpretations and aids disease prognosis.

Point-of-care testing: Compact automated cell counters suitable for near-patient testing are gaining traction. This eases accessibility in non-laboratory settings like hospitals and clinics.

Market Opportunities

Emerging markets: Developing countries in Asia Pacific and Latin America are expected to drive future growth opportunities due to increasing healthcare investments, rising affluence, and growing disease burden.

Cancer immunotherapy: Automated tools for tumor infiltrating lymphocytes enumeration can facilitate cancer immunotherapy and pave way for more personalized treatment regime

Impact of Covid-19 on Automated Cell Counters Market

The outbreak of COVID-19 pandemic has significantly impacted the global automated cell counters market. During the initial phase of the pandemic, many research studies and clinical trials were delayed or postponed as efforts were focused on developing vaccine and therapeutics for the novel coronavirus. This led to temporary decline in demand for automated cell counters. However, as the pandemic intensified, there was rising need for advanced diagnostic testing and research related to virus pathology. Automated cell counters found increased importance in applications like analyzing cell viability, concentration and differentation for vaccine development and testing. Many manufacturers also ramped up production of automated cell counters to aid hospitals and diagnostic labs overwhelmed due to patient surge.

In the post-pandemic scenario, the automated cell counters market is expected to witness steady growth. Researchers and pharma companies will continue efforts to gain deeper insights into SARS-CoV-2 virus through cell-based examination. There is also likelihood of pandemic preparedness programs which could mean more investments in cell analysis infrastructure. Further, demand from sectors like oncology is projected to boost market revenues. Meanwhile, key players are focusing on Developing integrated solutions with advanced features like artificial intelligence, internet of things and cloud connectivity to facilitate remote operations. This will allow greater accessibility and scale up testing capacity to deal with future health crises.

Automated Cell Counters Market in North America

North America dominates the global automated cell counters market, capturing over 40% share in terms of value. This can be primarily attributed to presence of highly advanced healthcare system and research infrastructure in the region particularly in the US. The favorable government policies supporting drug discovery and medical technology development also contribute to high market concentration. Furthermore, increasing incidence of chronic diseases like cancer has augmented clinical adoption of automated cell counters for diagnostic applications in the North American countries. Presence of leading industry players and access to skilled workforce further make the region highly lucrative. It is expected that technological advancements will drive continued market growth in the coming years.

Automated Cell Counters Market in Asia Pacific

The Asia Pacific region presents immense opportunities for the automated cell counters market and is emerging as the fastest growing regional market. Factors such as rising healthcare spending, growing middle class population with ability to afford advanced treatments, and improving pharmaceutical & biotechnology industry offer significant tailwinds. Countries like China, India and Japan are rapidly modernizing their healthcare infrastructure which provides a strong base for market expansion. Moreover, there is active presence of CROs and CMOs in the region which augments research outsourcing. This coupled with supportive initiatives of regional governments make Asia Pacific highly promising for automated cell counters market players. The market is forecast to be led by China aided by factors like government focus on indigenous drug development capabilities.

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191